[Form 3] Connect Biopharma Holdings Ltd Initial Statement of Beneficial Ownership
Connect Biopharma Holdings Ltd director Jean I Liu filed an initial ownership report detailing several stock options over Ordinary Shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Connect Biopharma Holdings Ltd director Jean I Liu filed an initial ownership report detailing several stock options over Ordinary Shares. The options have exercise prices that include $22.29, $4.12, $1.27, $1.18, $0.96 and $2.50, with expiration dates ranging from 2031 through 2036.
The filing notes that one stock option is already fully vested and exercisable, while another will fully vest and become exercisable on March 2, 2027. The report lists holdings only and does not show any purchases or sales.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
Footnotes (2)
- F1. The stock option is fully vested and exercisable.
- F2. The stock option fully vests and becomes exercisable on March 2, 2027.
AI-generated analysis. How Rhea-AI works. Not financial advice.
